home / stock / agn / agn news


AGN News and Press, Allergan plc From 11/25/19

Stock Information

Company Name: Allergan plc
Stock Symbol: AGN
Market: NYSE
Website: allergan.com

Menu

AGN AGN Quote AGN Short AGN News AGN Articles AGN Message Board
Get AGN Alerts

News, Short Squeeze, Breakout and More Instantly...

AGN - Merger Arbitrage Mondays - Novartis Confirms Acquisition Of The Medicines Company

Merger activity decreased, with three new deals announced and five deals closing. Deal Statistics: New Deals: The acquisition of Carolina Financial Corporation (CARO) by United Bankshares (UBSI) for $1.1 billion in an all-stock deal. Under the terms of the agreement, United will...

AGN - Tracking David Tepper's Appaloosa Management Portfolio - Q3 2019 Update

This article is part of a series that provides an ongoing analysis of the changes made to David Tepper's 13F portfolio on a quarterly basis. It is based on Appaloosa Management's regulatory 13F Form filed on 11/14/2019. Please visit our Tracking David Tepper's Appaloosa Management Portfolio...

AGN - Better Buy: AbbVie vs. GlaxoSmithKline

Big pharma stocks are a prized commodity among growth and income investors alike. The core reasons boil down to the fact that pharmaceuticals are an essential staple for millions of people, and the industry has been a hotbed of innovation over the past decade. Nonetheless, pharmaceutical stock...

AGN - HQH: Operating In A Wild Sector At A Steep Discount

This article was first published on October 20, 2019. Tekla Healthcare Investors ( HQH ) has been lagging the broader market, along with the rest of the healthcare sector as a whole. The continued rhetoric from presidential hopefuls and even the current White House administration has reall...

AGN - Allergan Announces Positive Phase 3 ACHIEVE II Trial Results for Ubrogepant Published in The Journal of the American Medical Association

DUBLIN , Nov. 19, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that positive results from ACHIEVE II (UBR-MD-02), a pivotal Phase 3 clinical trial evaluating the efficacy, safety and tolerability of ubrogepant, have been published in the November 19 th issue of The Jo...

AGN - Top Merger Stocks Held By Fund Managers, Mid-Q4 2019

Four times a year, I spend several hours combing through Form 13F filings from the hedge funds that specialize in M&A. I document and analyze which merger stocks the funds have bought and which ones they haven't. I then compile the top 10 stocks held in these funds and share it with everyo...

AGN - Merger Arbitrage Mondays - Nearly $12 Billion Of New Deals Announced

Merger activity increased with seven new deals announced and two deals closing. Deal Statistics New Deals The acquisition of Carbonite (CARB) by Open Text Corporation (OTEX) for $1.42 billion or $23.00 per share in cash. We added CARB as a potential deal to the Deals in the Work...

AGN - Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day

DUBLIN , Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX ® Cosmetic, has announced the first-ever National BOTOX ® Cosmetic Day kicking off on November 20 . The celebration recognizes the impact this iconic aesthetic brand, which is the #1 sell...

AGN - Better Buy: Eli Lilly vs. AbbVie

Neither Eli Lilly (NYSE: LLY) nor AbbVie (NYSE: ABBV) has provided much for investors to get excited about so far in 2019. Both big pharma stocks are down by single-digit percentages year to date. But Lilly and AbbVie each hold the potential to deliver more attractive returns down the st...

AGN - Tracking Seth Klarman's Baupost Group Holdings - Q3 2019 Update

This article is part of a series that provides an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarman’s regulatory 13F Form filed on 11/14/2019. Please visit our Tracking Seth Klarman’s Baupost Group Holdings...

Previous 10 Next 10